34 related articles for article (PubMed ID: 38678165)
21. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.
Bottomley A; Pe M; Sloan J; Basch E; Bonnetain F; Calvert M; Campbell A; Cleeland C; Cocks K; Collette L; Dueck AC; Devlin N; Flechtner HH; Gotay C; Greimel E; Griebsch I; Groenvold M; Hamel JF; King M; Kluetz PG; Koller M; Malone DC; Martinelli F; Mitchell SA; Moinpour CM; Musoro J; O'Connor D; Oliver K; Piault-Louis E; Piccart M; Pimentel FL; Quinten C; Reijneveld JC; Schürmann C; Smith AW; Soltys KM; Taphoorn MJB; Velikova G; Coens C;
Lancet Oncol; 2016 Nov; 17(11):e510-e514. PubMed ID: 27769798
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients.
Mol L; Ottevanger PB; Koopman M; Punt CJ
Eur J Cancer; 2016 Oct; 66():138-43. PubMed ID: 27573427
[TBL] [Abstract][Full Text] [Related]
23. Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial.
Cella D; Grünwald V; Nathan P; Doan J; Dastani H; Taylor F; Bennett B; DeRosa M; Berry S; Broglio K; Berghorn E; Motzer RJ
Lancet Oncol; 2016 Jul; 17(7):994-1003. PubMed ID: 27283863
[TBL] [Abstract][Full Text] [Related]
24. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors.
Howell D; Molloy S; Wilkinson K; Green E; Orchard K; Wang K; Liberty J
Ann Oncol; 2015 Sep; 26(9):1846-1858. PubMed ID: 25888610
[TBL] [Abstract][Full Text] [Related]
25. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.
Heng DY; Xie W; Regan MM; Harshman LC; Bjarnason GA; Vaishampayan UN; Mackenzie M; Wood L; Donskov F; Tan MH; Rha SY; Agarwal N; Kollmannsberger C; Rini BI; Choueiri TK
Lancet Oncol; 2013 Feb; 14(2):141-8. PubMed ID: 23312463
[TBL] [Abstract][Full Text] [Related]
26. A prognostic model for metastatic renal-cell carcinoma.
Galsky MD
Lancet Oncol; 2013 Feb; 14(2):102-3. PubMed ID: 23312462
[No Abstract] [Full Text] [Related]
27. General population norms for the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).
Butt Z; Peipert J; Webster K; Chen C; Cella D
Cancer; 2013 Jan; 119(2):429-37. PubMed ID: 22778010
[TBL] [Abstract][Full Text] [Related]
28. Baseline quality of life as a prognostic survival tool in patients receiving sunitinib for metastatic renal cell carcinoma.
Cella D; Bushmakin AG; Cappelleri JC; Charbonneau C; Michaelson MD; Motzer RJ
Br J Cancer; 2012 Feb; 106(4):646-50. PubMed ID: 22240794
[TBL] [Abstract][Full Text] [Related]
29. Everything you always wanted to know about evaluating prediction models (but were too afraid to ask).
Vickers AJ; Cronin AM
Urology; 2010 Dec; 76(6):1298-301. PubMed ID: 21030068
[No Abstract] [Full Text] [Related]
30. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature.
Valderas JM; Kotzeva A; Espallargues M; Guyatt G; Ferrans CE; Halyard MY; Revicki DA; Symonds T; Parada A; Alonso J
Qual Life Res; 2008 Mar; 17(2):179-93. PubMed ID: 18175207
[TBL] [Abstract][Full Text] [Related]
31. Karnofsky performance status revisited: reliability, validity, and guidelines.
Schag CC; Heinrich RL; Ganz PA
J Clin Oncol; 1984 Mar; 2(3):187-93. PubMed ID: 6699671
[TBL] [Abstract][Full Text] [Related]
32. Patient's self-reported quality of life as a prognostic factor in metastatic renal cell carcinoma initially treated with TKI: nomogram proposal.
Lendínez-Cano G; Vilches-Arenas Á; Congregado-Ruíz B; Medina-López R
World J Urol; 2024 Apr; 42(1):267. PubMed ID: 38678165
[TBL] [Abstract][Full Text] [Related]
33. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
